COMMUNIQUÉS West-GlobeNewswire

Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference
18/12/2025
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that that Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will present at the 44 th [...]
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
18/12/2025
Event to be held January 6th, 2026, at 10 a.m. EST BETHESDA, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the [...]
Abivax to be Added to Nasdaq Biotechnology Index
18/12/2025
Abivax to be Added to Nasdaq Biotechnology Index PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage [...]
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors
18/12/2025
FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the [...]
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
18/12/2025
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44 th Annual [...]
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
18/12/2025
NORTHFIELD, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized initial public offering of 248,439,654 shares of its Class A common stock at a [...]
Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD
18/12/2025
Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment MOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery [...]
Cue Biopharma Announces Proposed Public Offering
18/12/2025
BOSTON, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease- [...]
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
18/12/2025
GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of disease activity compared to placebo In the [...]
Talkspace Releases Family Guide on Why Stress Spikes in December, and How to Break the Cycle
18/12/2025
Therapists say academic and holiday pressures exacerbate teens’ stress levels, and there are steps parents can take to help. New York, NY , Dec. 18, 2025 (GLOBE NEWSWIRE) -- Talkspace has released a seasonal guide to [...]
Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees
18/12/2025
COPENHAGEN, Denmark, December 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a long-term incentive program for Executive Management as part of the annual [...]
Foundation for Sarcoidosis Research Publishes Comprehensive Voice of the Patient Report Following Externally Led PFDD Meeting with the FDA
18/12/2025
CHICAGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the release of its comprehensive Voice of the Patient report , capturing the powerful insights, lived [...]
Verano Founder and Chief Executive Officer George Archos Shares Celebratory Comments on Cannabis Rescheduling Announcement
18/12/2025
Verano’s active operations span 13 states, comprised of 15 8 dispensaries operating under the Zen Leaf ™ and MÜV ™ retail banners, and 15 cultivation and processing facilities with more than 1.1 million square feet of [...]
Organic & Natural Health to Address Policy, Integrity and Innovation at 2026 Industry Conference
18/12/2025
FT. LAUDERDALE, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Organic & Natural Health Association (Organic & Natural Health) will convene industry leaders, policymakers and changemakers for its 11th Annual [...]
Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision
18/12/2025
The contemplated financing transactions would provide up to $12 Million in capital to support Celularity’s strategic priorities around longevity and preservation of human performance. FLORHAM PARK, N.J., Dec. 18, 2025 ( [...]
Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth
18/12/2025
Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) ( [...]
AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
18/12/2025
PRESS RELEASE AB SCIENCE ANNOUNCES THE INITIATION OF COVERAGE OF ITS STOCK BY MAXIM GROUP WITH A TARGET PRICE OF EUR 4.0 PER SHARE Paris, December 18, 2025, 7.15pm CET AB Science SA (Euronext - FR0010557264 - AB) [...]
AB Science annonce l’initiation de la couverture de son titre par Maxim Group avec un objectif de cours de 4,0 euros par action
18/12/2025
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE L’INITIATION DE LA COUVERTURE DE SON TITRE PAR MAXIM GROUP AVEC UN OBJECTIF DE COURS DE 4,0 EUROS PAR ACTION Paris, le 18 décembre 2025, 19h15 CET AB Science SA (Euronext - [...]
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK
18/12/2025
Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® Kit TYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical [...]

Pages